Semaglutide with Glycine is a compounded, physician-prescribed injectable therapy that supports powerful, sustained weight loss while promoting cellular recovery and metabolic resilience. This enhanced formulation combines semaglutide, a GLP-1 receptor agonist, with glycine, a conditionally essential amino acid known for its roles in detoxification, inflammation control, and mitochondrial function.
Together, they offer a next-generation solution for patients seeking clinically backed fat loss with enhanced recovery and metabolic wellness.
Semaglutide mimics a natural hormone called GLP-1 (glucagon-like peptide-1), which:
Slows digestion (gastric emptying)
Regulates appetite and cravings
Improves insulin sensitivity
Lowers blood sugar levels
Glycine, while not directly tied to weight loss, supports:
Mitochondrial function and metabolic energy production
Anti-inflammatory and antioxidant pathways
Sleep quality, cognitive function, and tissue repair
The addition of glycine may help reduce the systemic stress of rapid weight loss, support recovery, and enhance metabolic flexibility during your transformation.
Appetite and Craving Control
Semaglutide reduces hunger signals and increases satiety, helping you eat less without feeling deprived.
Clinically Proven Weight Loss
Studies show semaglutide can help patients lose 10–15% of total body weight when used with diet and lifestyle changes.
Enhanced Recovery & Resilience
Glycine supports cellular repair, glutathione production, and mitochondrial health—critical during caloric restriction.
Improved Sleep & Mental Clarity
Glycine may promote better sleep quality and cognitive performance, which can impact willpower and adherence.
Once-Weekly Convenience
Administered via subcutaneous injection just once per week, under provider guidance.
Semaglutide (Compounded):
A GLP-1 receptor agonist that regulates appetite, slows gastric emptying, and helps improve glucose metabolism.
Glycine:
A conditionally essential amino acid that plays a key role in detoxification, inflammation control, neurotransmitter balance, and collagen formation.
Formulated by a licensed compounding pharmacy. Dosing is personalized based on individual tolerance and health goals.
Prescription Required
This is a prescription-only compounded medication and should be used under the supervision of a licensed provider.
Not for All Patients
Contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2.
Side Effects May Include:
Nausea, constipation, fatigue, mild injection site reactions. Glycine is generally well tolerated and may reduce inflammation-related symptoms.
Monitoring Recommended:
Periodic check-ins and lab monitoring (e.g., glucose, kidney function, electrolytes) are advised during treatment.
Not a Quick Fix
Best results are achieved when semaglutide with glycine is combined with nutritional guidance, physical activity, and long-term lifestyle changes.
Pregnancy & Breastfeeding
Not recommended during pregnancy or while breastfeeding. Use only under professional supervision.
